SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-16-137763
Filing Date
2016-12-05
Accepted
2016-12-02 18:19:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v454363_sc13da.htm SC 13D/A 59347
2 EXHIBIT 6 v454363_ex6.htm EX-99.6 7371
  Complete submission text file 0001144204-16-137763.txt   68312
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Subject) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87796 | Film No.: 162032325
SIC: 2834 Pharmaceutical Preparations

Mailing Address 151 TREMONT ST. PENTHOUSE BOSTON MA 02111
Business Address 151 TREMONT ST. PENTHOUSE BOSTON MA 02111 617-497-3538
Novalere Holdings, LLC (Filed by) CIK: 0001639387 (see all company filings)

IRS No.: 472866278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A